Astellas Pharma (4503.TSE) Q2 2023 Earnings

Apr 27Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-25
-4
18
39

Details

Expected EPS
-14
Actual EPS
-25
Surprise EPS
-12
Surprise Percent
-82.33%

Description

⁨Astellas Pharma⁩ (⁦4503.TSE⁩) has reported earnings of ⁦-25⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts